prednisolone has been researched along with Leukemia, Myelomonocytic, Juvenile in 1 studies
Prednisolone: A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states.
prednisolone : A glucocorticoid that is prednisone in which the oxo group at position 11 has been reduced to the corresponding beta-hydroxy group. It is a drug metabolite of prednisone.
Leukemia, Myelomonocytic, Juvenile: A leukemia affecting young children characterized by SPLENOMEGALY, enlarged lymph nodes, rashes, and hemorrhages. Traditionally classed as a myeloproliferative disease, it is now considered a mixed myeloproliferative-mylelodysplastic disorder.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tüfekçi, Ö | 1 |
| Ören, H | 1 |
| Demir Yenigürbüz, F | 1 |
| Gözmen, S | 1 |
| Karapınar, TH | 1 |
| İrken, G | 1 |
1 other study available for prednisolone and Leukemia, Myelomonocytic, Juvenile
| Article | Year |
|---|---|
Management of Two Juvenile Myelomonocytic Leukemia Patients According to Clinical and Genetic Features.
Topics: Abnormalities, Multiple; Allografts; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemot | 2015 |